155 related articles for article (PubMed ID: 11870629)
21. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
Ilyinskii PO; Wang R; Balk SP; Exley MA
J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
[TBL] [Abstract][Full Text] [Related]
22. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
[TBL] [Abstract][Full Text] [Related]
23. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.
Elewaut D; Lawton AP; Nagarajan NA; Maverakis E; Khurana A; Honing S; Benedict CA; Sercarz E; Bakke O; Kronenberg M; Prigozy TI
J Exp Med; 2003 Oct; 198(8):1133-46. PubMed ID: 14557411
[TBL] [Abstract][Full Text] [Related]
24. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
Niederkorn JY; Mayhew E
Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
[TBL] [Abstract][Full Text] [Related]
25. Regulation of immune responses by CD1d-restricted natural killer T cells.
Van Kaer L
Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
[TBL] [Abstract][Full Text] [Related]
26. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
27. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
28. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
[TBL] [Abstract][Full Text] [Related]
29. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.
Dougan SK; Salas A; Rava P; Agyemang A; Kaser A; Morrison J; Khurana A; Kronenberg M; Johnson C; Exley M; Hussain MM; Blumberg RS
J Exp Med; 2005 Aug; 202(4):529-39. PubMed ID: 16087713
[TBL] [Abstract][Full Text] [Related]
30. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP
Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651
[TBL] [Abstract][Full Text] [Related]
31. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells.
Elewaut D; Shaikh RB; Hammond KJ; De Winter H; Leishman AJ; Sidobre S; Turovskaya O; Prigozy TI; Ma L; Banks TA; Lo D; Ware CF; Cheroutre H; Kronenberg M
J Exp Med; 2003 Jun; 197(12):1623-33. PubMed ID: 12810685
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization.
Hijioka K; Sonoda KH; Tsutsumi-Miyahara C; Fujimoto T; Oshima Y; Taniguchi M; Ishibashi T
Biochem Biophys Res Commun; 2008 Sep; 374(1):38-43. PubMed ID: 18606153
[TBL] [Abstract][Full Text] [Related]
33. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
[TBL] [Abstract][Full Text] [Related]
34. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
35. IFN-beta-mediated up-regulation of CD1d in bacteria-infected APCs.
Raghuraman G; Geng Y; Wang CR
J Immunol; 2006 Dec; 177(11):7841-8. PubMed ID: 17114455
[TBL] [Abstract][Full Text] [Related]
36. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance.
Sonoda KH; Faunce DE; Taniguchi M; Exley M; Balk S; Stein-Streilein J
J Immunol; 2001 Jan; 166(1):42-50. PubMed ID: 11123275
[TBL] [Abstract][Full Text] [Related]
37. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
Belperron AA; Dailey CM; Bockenstedt LK
J Immunol; 2005 May; 174(9):5681-6. PubMed ID: 15843569
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
Ström A; Wigren M; Hultgårdh-Nilsson A; Saxena A; Gomez MF; Cardell S; Fredrikson GN; Nilsson J
Circ Res; 2007 Oct; 101(8):e83-9. PubMed ID: 17885216
[TBL] [Abstract][Full Text] [Related]
39. Tolerogenic APC generate CD8+ T regulatory cells that modulate pulmonary interstitial fibrosis.
Zhang-Hoover J; Stein-Streilein J
J Immunol; 2004 Jan; 172(1):178-85. PubMed ID: 14688324
[TBL] [Abstract][Full Text] [Related]
40. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
Dufour FD; Silveira PA; Baxter AG
J Immunotoxicol; 2008 Apr; 5(2):249-57. PubMed ID: 18569396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
